Download PDF
Am J Perinatol 1996; 13(2): 69-71
DOI: 10.1055/s-2007-994294
ORIGINAL ARTICLE

© 1996 by Thieme Medical Publishers, Inc.

Clinical Commentary: The Bromocriptine (Parlodel) Controversy and Recommendations for Lactation Suppression

William E. Rayburn
  • Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma
Further Information

Publication History

Publication Date:
04 March 2008 (online)

    Permissions and Reprints

ABSTRACT

Mounting concerns about bromocriptine (Parlodel) and rare cardiovascular and cerebrovascular accidents have prompted the manufacturer to remove the drug from the market for use in postpartum lactation suppression. No drug is available now or will be in the. foreseeable future for this indication. This change in prescribing practice should alert the physician to counseling the expectant mother about the merits of breast feeding and about simple, non-pharmacologic methods of suppressing milk production.

Keywords

Lactation suppression - breast feeding - breast engorgement

      >